Key result
Dopamine optimizes systemic hemodynamics at 4-6 microg/kg/min, but renal gains peak lower and falter in NYHA IV.
Why the study?
Whether the short-term systemic and renal hemodynamic response to dopamine is influenced by the clinical severity of congestive heart failure was uncertain.
Does the clinical severity of congestive heart failure (NYHA class III vs IV) influence the short-term systemic and renal hemodynamic response to increasing doses of intravenous dopamine?
Does the clinical severity of congestive heart failure (NYHA class III vs IV) influence the short-term systemic and renal hemodynamic response to increasing doses of intravenous dopamine?
Greater clinical severity of congestive heart failure (NYHA class IV vs III) selectively impairs the renal vasodilating and hemodynamic benefits of dopamine without blunting its systemic hemodynamic response, and optimal hemodynamic improvement requires higher dopamine doses (4-6 microg/kg/min) than traditionally reported.
Answers are grounded in this paper and cite their sources.
May support severity-tailored dopamine dosing for renal hemodynamics in decompensated HF; leaves open outcome impact and needs RCTs.
Objective To determine whether the short-term systemic and renal hemodynamic response to dopamine is influenced by clinical severity of congestive heart failure. Design Effects of increasing doses of dopamine were assessed in patients consecutively admitted for acutely decompensated congestive heart failure. Setting Intensive care unit. Patients We enrolled 16 congestive heart failure patients stratified by clinical severity (New York Heart Association [NYHA] class III, n = 8; NYHA class IV, n = 8) and two additional NYHA class III patients as controls. Interventions Measurements were carried out throughout five 20-min experimental periods: baseline, dopamine infusion at 2, 4, and 6 microg x kg(-1) x min(-1), and recovery. Controls received a similar amount of saline. Measurements and main results Systemic and renal hemodynamics were determined respectively by right cardiac catheterization and radioisotopes (iodine 131-labeled hippuran and iodine 125-labeled iothalamate clearance). The peak increase in heart rate and cardiac index occurred at a dopamine dose of 4-6 microg x kg(-1) x min(-1). The dose-response relation was similar in NYHA classes III and IV. Improvement in effective renal plasma flow and glomerular filtration rate, peaking at 4 microg x kg(-1) x min(-1), was more rapid and marked in NYHA class III than class IV patients, in whom the renal fraction of cardiac output failed to increase. The systemic and renal effects of dopamine were independent of age. No change occurred in controls. Conclusions The dose of dopamine producing an optimal improvement of systemic and renal hemodynamics in congestive heart failure is higher than usually reported. A greater clinical severity of congestive heart failure impairs the renal effects of dopamine, probably through a selective loss in renal vasodilating capacity.
No takes yet. Share an insight, caveat, or question.
Ungar et al. (2004) studied Acutely decompensated congestive heart failure (n=18). Dopamine infusion vs. Saline infusion (n=2 NYHA class III controls) and comparison between NYHA class III (n=8) and NYHA class IV (n=8) was evaluated on Systemic hemodynamics (heart rate, cardiac index) and renal hemodynamics (effective renal plasma flow, glomerular filtration rate, renal fraction of cardiac output). Dopamine infusion peaked systemic hemodynamics at 4-6 microg/kg/min similarly across NYHA classes, while renal hemodynamic improvement peaked at 4 microg/kg/min and was impaired in functional class IV.
Synapse has enriched 10 related papers. Consider them for comparative context: